- Home
- OUSTW vs ENVB Comparison
OUSTW vs ENVB Comparison
Compare OUSTW & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUSTW
- ENVB
- Stock Information
- Founded
- OUSTW N/A
- ENVB 1994
- Country
- OUSTW United States
- ENVB United States
- Employees
- OUSTW N/A
- ENVB N/A
- Industry
- OUSTW Industrial Machinery/Components
- ENVB Biotechnology: Pharmaceutical Preparations
- Sector
- OUSTW Industrials
- ENVB Health Care
- Exchange
- OUSTW Nasdaq
- ENVB Nasdaq
- Market Cap
- OUSTW 3.1M
- ENVB 3.3M
- IPO Year
- OUSTW N/A
- ENVB N/A
- Fundamental
- Price
- OUSTW $0.04
- ENVB $1.36
- Analyst Decision
- OUSTW
- ENVB
- Analyst Count
- OUSTW 0
- ENVB 0
- Target Price
- OUSTW N/A
- ENVB N/A
- AVG Volume (30 Days)
- OUSTW N/A
- ENVB 564.4K
- Earning Date
- OUSTW N/A
- ENVB 03-25-2025
- Dividend Yield
- OUSTW N/A
- ENVB N/A
- EPS Growth
- OUSTW N/A
- ENVB N/A
- EPS
- OUSTW N/A
- ENVB N/A
- Revenue
- OUSTW N/A
- ENVB N/A
- Revenue This Year
- OUSTW N/A
- ENVB N/A
- Revenue Next Year
- OUSTW N/A
- ENVB N/A
- P/E Ratio
- OUSTW N/A
- ENVB N/A
- Revenue Growth
- OUSTW N/A
- ENVB N/A
- 52 Week Low
- OUSTW N/A
- ENVB $1.26
- 52 Week High
- OUSTW N/A
- ENVB $657.00
- Technical
- Relative Strength Index (RSI)
- OUSTW N/A
- ENVB 16.91
- Support Level
- OUSTW N/A
- ENVB $1.26
- Resistance Level
- OUSTW N/A
- ENVB $1.70
- Average True Range (ATR)
- OUSTW 0.00
- ENVB 0.17
- MACD
- OUSTW 0.00
- ENVB 2.34
- Stochastic Oscillator
- OUSTW 0.00
- ENVB 12.20
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.